Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Acetoacetic acid sodium salt 是一种内源性的非酯化脂肪酸代谢物,与人类糖尿病的发展相关。它诱导氧化应激,抑制牛肝细胞中极低密度脂蛋白的组装。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 397 | 现货 | ||
2 mg | ¥ 582 | 现货 | ||
5 mg | ¥ 927 | 现货 | ||
10 mg | ¥ 1,490 | 现货 | ||
25 mg | ¥ 2,530 | 现货 | ||
50 mg | ¥ 3,720 | 现货 | ||
100 mg | ¥ 5,290 | 现货 | ||
500 mg | ¥ 10,700 | 现货 |
产品描述 | Acetoacetic acid sodium salt is a metabolite of non-esterified fatty acids, involved in the development of human diabetes. |
体外活性 | Acetoacetic acid sodium salt induces oxidative stress to inhibit the assembly of very-low-density lipoprotein in bovine hepatocytes. Acetoacetic acid (0.6, 2.4, 4.8 mM) increases malondialdehyde (MDA) content in high-dose group (GH) group, decreases mRNA expression of Mn-SOD, Cu/Zn SOD, and glutathione peroxidase (GSH-Px) in all groups, lowers catalase (CAT) mRNA expression in the medial-dose group (GM), and GH groups. In addition, Acetoacetic acid down-regulates the mRNA expression of apolipoprotein B100 (ApoB100), apolipoprotein E (ApoE), and low-density lipoprotein receptor (LDLR). Thus, VLDL assembly is decreased and triglyceride (TG) accumulation is increased in these bovine hepatocytes. |
别名 | 乙酰乙酸钠, 3-氧代丁酸钠盐 |
分子量 | 124.07 |
分子式 | C4H5NaO3 |
CAS No. | 623-58-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
H2O: 50 mg/mL (403.00 mM), Sonication is recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
H2O | 1 mM | 8.06 mL | 40.2998 mL | 80.5997 mL | 201.4992 mL |
5 mM | 1.612 mL | 8.06 mL | 16.1199 mL | 40.2998 mL | |
10 mM | 0.806 mL | 4.03 mL | 8.06 mL | 20.1499 mL | |
20 mM | 0.403 mL | 2.015 mL | 4.03 mL | 10.075 mL | |
50 mM | 0.1612 mL | 0.806 mL | 1.612 mL | 4.03 mL | |
100 mM | 0.0806 mL | 0.403 mL | 0.806 mL | 2.015 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Acetoacetic acid sodium salt 623-58-5 Others inhibit Endogenous Metabolite Acetoacetic acid sodium Inhibitor 乙酰乙酸钠 Acetoacetic acid 3-氧代丁酸钠盐 inhibitor